Drug Patent Expirations for Aug 24, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

SAXENDA (liraglutide recombinant)
Novo Nordisk Inc
Patent number: 7,235,627
Expiration Date: Aug 22, 2017

SAXENDA (liraglutide recombinant)
Novo Nordisk Inc
Patent number: 6,458,924
Expiration Date: Aug 22, 2017

VICTOZA (liraglutide recombinant)
Novo Nordisk Inc
Patent number: 7,235,627
Expiration Date: Aug 22, 2017

VICTOZA (liraglutide recombinant)
Novo Nordisk Inc
Patent number: 6,458,924
Expiration Date: Aug 22, 2017

XULTOPHY 100/3.6 (insulin degludec; liraglutide)
Novo Nordisk Inc
Patent number: 6,458,924
Expiration Date: Aug 22, 2017

XULTOPHY 100/3.6 (insulin degludec; liraglutide)
Novo Nordisk Inc
Patent number: 7,235,627
Expiration Date: Aug 22, 2017

DULERA (formoterol fumarate; mometasone furoate)
Merck Sharp Dohme
Patent number: 6,068,832
Expiration Date: Aug 27, 2017

ASMANEX HFA (mometasone furoate)
Merck Sharp Dohme
Patent number: 6,068,832
Expiration Date: Aug 27, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


This post was originally published on this site
Comments are closed.